What is the Impact Factor of Clinical and Experimental Rheumatology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Clinical and Experimental Rheumatology is 3.20, ranking in quartile Q2 of Web of Science (SCIE).

Is Clinical and Experimental Rheumatology indexed in Web of Science or Scopus?

Yes, Clinical and Experimental Rheumatology is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.038 (Q2) and an H-index of 114.

Who publishes Clinical and Experimental Rheumatology and what is the Article Processing Charge (APC)?

Clinical and Experimental Rheumatology is published by Clinical and Experimental Rheumatology S.A.S.. The estimated Article Processing Charge (APC) is approximately $3,335 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Clinical and Experimental Rheumatology?

The official ISO-4 abbreviation of Clinical and Experimental Rheumatology is "CLIN EXP RHEUMATOL". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q2SCImago #4,608Hybrid

Clinical and Experimental Rheumatology

Abbreviation (ISO):CLIN EXP RHEUMATOL

•

Identifier (ISSN):0392-856X(Print)/1593-098X(Online)

•

Publisher:Clinical and Experimental Rheumatology S.A.S.

Official Website Submission Portal Compare

Clarivate IF (2026)

3.2↓ -0.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Clinical and Experimental Rheumatology

WoS Q2

Annual Impact Factor Metric

Current (2026):3.2

Scopus SJR & RankScopus Q2

1.038

#4,608

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

114

114 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate20.6%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

270articles/year

1.53% Gold OA•82.89% Original Research

Aims & Scope

Clinical and Experimental Rheumatology is a bi-monthly international peer-reviewed journal which has been covering all clinical, experimental and translational aspects of musculoskeletal, arthritic and connective tissue diseases since 1983.

Topics Covered (Recognized by AI)

Medicine99.9%Internal medicine94.7%Biology91%Pathology79.3%Immunology75.4%Genetics52.9%Disease52%Surgery46.2%Chemistry35.2%Psychology34.5%Rheumatoid arthritis33.1%Biochemistry32.1%Psychiatry29.3%Arthritis27.8%Dermatology27.1%Radiology26.8%Antibody26.2%Endocrinology25.5%

Primary Research Areas

Medicine Rheumatology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

RHEUMATOLOGY

Rank21/58

IndexSCIE

JCISCIE2026

RHEUMATOLOGY

Rank18/58

IndexSCIE

Category	Index	Rank	Quartile
RHEUMATOLOGY	JCRSCIE	21/58	Q2
RHEUMATOLOGY	JCISCIE	18/58	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.2

Articles / Year131

Total Citations7

2025

IF3.3

Articles / Year332

Total Citations246

2024

IF3.4

Articles / Year319

Total Citations735

2023

IF3.7

Articles / Year308

Total Citations1,456

2022

IF4.862

Articles / Year433

Total Citations3,941

Year	Impact Factor	Articles / Year	Total Citations
2026	3.2	131	7
2025	3.3	332	246
2024	3.4	319	735
2023	3.7	308	1,456
2022	4.862	433	3,941
2021	4.473	557	6,682
2020	3.319	43	1,770
2019	3.238	2	0
2018	3.201	24	79
2017	—	3	13
2016	—	20	7
2015	—	8	0

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,608Scopus Q2SCImago Profile

Scopus Coverage:1983-2026

•

Scopus Broad Areas:Immunology and MicrobiologyMedicine

Scopus Citation Rank (SJR)Q2

1.038

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.68

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,335 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,796

3-Year Documents1,058

Citable Documents858

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate51.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ2

Immunology and AllergyQ2

RheumatologyQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 20.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区RHEUMATOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Clinical and Experimental Rheumatology (abbr: CLIN EXP RHEUMATOL, ISSN: 0392-856X) is a peer-reviewed international scholarly journal in the field of Medicine, published by Clinical and Experimental Rheumatology S.A.S. in Italy. The periodical holds a Journal Impact Factor (JIF) of 3.20, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.038 (Q2), an H-index of 114.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 270 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,335 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.